Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 109 articles for Sofosbuvir

Then save them, add them to a collection or cite them together.
  1. Research article · 21 Apr 2025

    Estimation the Role of Interleukin-18 Promoter Polymorphisms (-607 C/A and 137 G/C) in Patient Infected with Hepatitis C Virus and Treatment with Sofosbuvir Drug

    Journal of Virology & Antiviral Research · Volume 14, Issue 2

    caused patients to respond or not during sofosbuvir treatment. Methods: Using reverse transcriptase-PCR technology, patients in our study were split into two groups: Those who were anti-HCV positive ... negative (n=55)…

  2. Review article · 2020

    Challenges in treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients by direct acting antivirals (sofosbuvir and daclatasvir)

    Systematic Reviews in Pharmacy · Volume 11, Issue 12

    individuals is considered a priority. Objectives: to evaluate the safety and efficacy of DAAs (sofosbuvir & daclatasvir) in treating chronic HCV in HCV-HIV co-infected Egyptian patients. Patients and methods ... were…

  3. Research article · 22 Mar 2018

    Chemometrically Assisted RP-HPLC and Spectroscopic Method Development for Simultaneous Multi-Component Analysis of Ledipasvir and Sofosbuvir in Pure and Pharmaceutical Formulation

    Der Pharmacia Lettre · Volume 10, Issue 3

    Objective: A strategic quantitative analysis of Ledipasvir (LEDI) and Sofosbuvir (SOF) has been developed in Bulk and pharmaceutical (Tablet) dosage form with a reliable, Precise and sensitive First-Order Derivative

  4. Research article · 2017

    Interleukin-28B Polymorphism is a Pharmacogenetic Predictor during Sofosbuvir Plus Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C Egyptian Patients

    Journal of Pharmacogenomics & Pharmacoproteomics · Volume 8, Issue 1

    step in personalized HCV therapy and pharmacogenomics. Methods: CHC Egyptian patients were received sofosbuvir (SOF) plus pegylated interferon (PEG-IFN) and ribavirin (RBV) for 12 weeks. A total

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels